Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Dry AMD affects part of the eye’s retina that allows for clear central vision.

Experimental drug shows promise for sight-stealing eye condition

Dry macular degeneration - Diagnosis and treatment - Mayo Clinic

LASIK, Cornea & Cataract Specialty Center

Geographic atrophy: What to know and why

Diet, exercise, smoking habits and genes interact to affect AMD risk

IJMS, Free Full-Text

Narrative review of risuteganib for the treatment of dry age

NEI Research News National Eye Institute

Aviceda begins part 2 of Phase II/III trial for geographic atrophy